Barinthus Biotherapeutics (BRNS) Short-Term Debt issuances (2022)

Barinthus Biotherapeutics (BRNS) has 1 years of Short-Term Debt issuances data on file, last reported at $159000.0 in Q1 2022.

• Quarterly Short-Term Debt issuances changed N/A year-over-year to $159000.0 in Q1 2022, while the trailing twelve-month figure through Dec 2022 was $159000.0 (changed N/A YoY) and the FY2022 annual result came in at $159000.0, changed N/A from the prior year.
• Short-Term Debt issuances was little changed at $159000.0 in Q1 2022.
• In the past five years, Short-Term Debt issuances ranged from a high of $159000.0 in Q1 2022 to a low of $159000.0 in Q1 2022.